PCN27 COST-EFFECTIVENESS AND COST-UTILITY OF FENTANYL TTS (DUROGESIC® 25, 50) VS. SR/IR ORAL MORPHINES IN THE MANAGEMENT OF CHRONIC CANCER PAIN
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63457-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)63457-2/fulltext
Title :
PCN27 COST-EFFECTIVENESS AND COST-UTILITY OF FENTANYL TTS (DUROGESIC® 25, 50) VS. SR/IR ORAL MORPHINES IN THE MANAGEMENT OF CHRONIC CANCER PAIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63457-2&doi=10.1016/S1098-3015(10)63457-2
First page :
Section Title :
Open access? :
No
Section Order :
310